← Blog Home

Winlevi clascoterone: what the label says about this cream

A plain unmarked white aluminum cream tube lying on a pale stone counter with a small swirl of white cream beside its open cap

Quick answer: Winlevi (clascoterone) is a prescription cream for acne vulgaris in patients 12 years and older, according to its FDA-approved label. It’s an androgen receptor inhibitor applied as a thin layer twice a day. In the two 12-week trials it beat a plain vehicle cream, though most people weren’t clear or almost clear at week 12. A dermatologist decides whether it fits your case, and a prescription is never guaranteed.

This page sticks to the label and the trial tables. It also says where the label itself admits uncertainty. You’ll also see how the cream differs from retinoids and from oral anti-androgens, and what to ask before you start.

What is Winlevi, and what does clascoterone do to the skin?

Winlevi is the brand name, and clascoterone is the active ingredient in the 1% cream. The label calls it an androgen receptor inhibitor indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Androgens are hormones that both men and women make, and they act on oil glands in the skin.

The label is candid about one point. Its mechanism of action section says that clascoterone is an androgen receptor inhibitor and that the mechanism of action of the cream for acne is unknown. So “it blocks androgen receptors” describes the drug class. It doesn’t fully explain why the cream helps pimples.

It’s a cream you apply to the skin, and it’s not a pill. That matters because the oral anti-androgen spironolactone works through the whole body, while Winlevi is applied only to the affected areas. The label still warns that some of the drug can reach the bloodstream, and the safety section below covers what that means.

How does the label say to use Winlevi?

The label’s directions are brief, and they start with cleansing. Cleanse the affected area gently, and after the skin is dry, apply a thin uniform layer twice per day, in the morning and the evening. The label describes a thin layer of approximately 1 gram to the affected area each time.

A white ceramic bathroom sink with a plain folded white towel and an unmarked frosted pump bottle beside a small dab of white cream on a ceramic dish

Keep it away from your eyes, mouth and other mucous membranes. The label says that if contact happens, you should rinse thoroughly with water. It’s also for topical use only, so it’s not for ophthalmic, oral or vaginal use.

The Patient Information adds a few practical lines. Wash your hands after applying the cream. Avoid using it on cuts, abrasions, eczema or sunburned skin. Avoid products that may dry or irritate your skin, such as medicated or abrasive soaps and cleansers, strong drying cosmetics, and products high in alcohol, astringents, spices or lime.

In pharmacy logistics, transfer day is the friction point. A prescription that moves between pharmacies loses days because neither pharmacy owns the clock during the handoff. Winlevi adds a wrinkle for the pharmacy. The label says the tube is stored in a refrigerator before dispensing, and the pharmacist then tells you to keep it at room temperature while you use it. Ask whichever pharmacy fills it how that step works, so your first tube isn’t delayed. The label also says to discard the unused cream 180 days after dispensing or 1 month after first opening, whichever is sooner, so plan refill timing with your pharmacy.

Does Winlevi work, and what did the trials show?

The label summarizes two identical multicenter, randomized, double-blind, vehicle-controlled trials. They enrolled 1,421 people 12 and older with facial acne vulgaris who applied Winlevi or a vehicle cream twice daily for 12 weeks. Of those, 641 were 12 to 17 years old and 780 were 18 or older.

Success was defined as at least a 2-point improvement on the Investigator Global Assessment plus a score of clear or almost clear. At week 12 that happened in 18.8% of the Winlevi group in trial 1 against 8.7% on vehicle. In trial 2 the figures were 20.9% against 6.6%.

Lesion counts moved in the same direction. In trial 1 the mean percent reduction in inflammatory lesions was 44.6% on Winlevi and 36.3% on vehicle. In trial 2 the figures were 47.1% against 29.7%. For non-inflammatory lesions, the mean percent reduction was 32.6% against 21.8% in trial 1 and 29.6% against 15.7% in trial 2.

Read those numbers plainly, without spin. The cream did better than vehicle in both trials, and the vehicle group improved too. The measure of success was strict, and roughly four in five people on Winlevi in these trials weren’t clear or almost clear at week 12. About 83% of trial participants had moderate acne at the start, and the rest had severe acne. The label’s table doesn’t break results out by severity, so it can’t tell you how the cream would perform on scarring acne.

The American Academy of Dermatology’s acne guideline, published in 2024, makes strong recommendations for benzoyl peroxide, topical retinoids, topical antibiotics and oral doxycycline. We haven’t verified guideline language on clascoterone, so we don’t quote one here. Ask your dermatologist how it compares with those standard options for your skin.

What side effects does the label list?

The most common adverse reactions, in 7 to 12% of patients, were erythema or reddening, pruritus and scaling or dryness. Edema, stinging and burning occurred in more than 3% of patients. The label adds that these were reported in a similar percentage of people treated with vehicle.

An unmarked white moisturizer jar, a frosted pump bottle and a folded white towel arranged on a pale tiled bathroom shelf in soft daylight

The local skin reaction table shows that overlap. Redness was reported in 12.2% of the Winlevi group and 15.4% of the vehicle group. Scaling or dryness was 10.5% against 10.4%, and itching was 7.7% against 8.2%. If irritation develops, the label says to discontinue the cream or reduce how often it’s applied, so tell your dermatologist.

The label says to avoid products that dry or irritate the skin, so settle your cleanser and moisturizer before the first application. Our post on a skincare routine on acne medication covers the basics.

What are the less common safety points?

Two warnings deserve a plain explanation. The first is hypothalamic-pituitary-adrenal axis suppression, which means the adrenal system can make less of its own hormones. The label says it was observed and may occur during or after treatment. In a pharmacokinetic study, adults used about 6 grams twice daily for 2 weeks, far above the labeled 1 gram per application. It showed up in 1 of 20 adults and 2 of 22 adolescents. All returned to normal function 4 weeks after treatment ended.

The label says conditions that increase absorption include use over large surface areas, prolonged use and occlusive dressings. If suppression develops, an attempt should be made to withdraw the drug. It also notes that pediatric patients may be more susceptible to systemic toxicity. The Patient Information lists symptoms of adrenal insufficiency as a serious side effect and says your healthcare provider may stop treatment if you develop adrenal problems.

The second safety point is potassium. The label lists hyperkalemia among the adverse reactions identified in trials and long-term safety studies, and it says elevated potassium levels were observed in some subjects. In the label’s pharmacodynamics data, shifts from normal to elevated potassium occurred in 5% of clascoterone-treated subjects and 4% of vehicle-treated subjects.

The label also lists polycystic ovaries and amenorrhea among adverse reactions from clinical trials and long-term safety studies. Mention both to your dermatologist if they apply to you, along with every medicine and supplement you take.

Is Winlevi safe during pregnancy or breastfeeding?

The label says there are no available data on Winlevi use in pregnant women to evaluate the risk of major birth defects, miscarriage or other outcomes. In animal studies, subcutaneous clascoterone given to pregnant rats at 8 times the maximum recommended human dose increased malformations. In rabbits, 39 times the maximum recommended human dose increased post-implantation loss and resorptions.

For breastfeeding, the label says there are no data on whether clascoterone passes into human milk or affects the baby. It says the developmental and health benefits of breastfeeding should be weighed against the mother’s need for the drug. Tell your dermatologist if you’re pregnant, plan to become pregnant or are nursing before you start any prescription.

How is Winlevi different from retinoids and spironolactone?

Retinoids and Winlevi are different drug classes. Adapalene and tretinoin are topical retinoids, and our posts on adapalene vs tretinoin and adapalene and benzoyl peroxide cover them. Clascoterone isn’t a retinoid, so it’s not the same thing as retinol, and the label describes it as an androgen receptor inhibitor.

Oral spironolactone is the other drug that people compare with it. The American Academy of Dermatology says dermatologists have prescribed spironolactone to treat acne in women for many years. It also says spironolactone isn’t prescribed to treat acne in men because of side effects. Winlevi’s label doesn’t restrict the indication by sex, and the trials included 62% females and 38% males.

Our posts on spironolactone for acne and hormones and acne in men go deeper on the oral side. The label says to limit use with other potentially irritating topical products, so ask your dermatologist before you add anything. An antibiotic gel such as the one in our clindamycin benzoyl peroxide post has its own rules.

What should you ask a dermatologist about Winlevi?

Bring questions that the label can’t answer for you. Ask whether your acne pattern and severity make this cream a reasonable option, and how it would fit with anything you already use. Ask how long a fair trial should last and what would count as a reason to change course.

Also ask which parts of your face or body the cream should cover. The label ties higher absorption to large surface areas, so the answer matters. Mention any history of adrenal problems, potassium issues or missing periods.

The Goal Is Clear doesn’t promise any specific cream. A board-certified dermatologist licensed in your state reviews every case, and TGIC says plans can include prescription topicals, oral medications or, when clinically appropriate, Accutane® (isotretinoin) with iPledge support. The dermatologist decides after reviewing your case, and a prescription is never guaranteed.

Medication is billed separately by the partner pharmacy, which runs your insurance, and our pricing page and Accutane® cost FAQ explain the split. For TGIC’s Accutane® prescriptions, some eligible insured patients pay as low as $0, though copays vary. That figure isn’t a price for Winlevi.

Common questions about Winlevi and clascoterone

Is Winlevi the same as retinol? No, those are two different kinds of drug. Retinol is a vitamin A derivative sold in skin care, and the Winlevi label describes clascoterone as an androgen receptor inhibitor. Our post on adapalene vs retinol explains the retinoid ladder.

Who can use Winlevi for acne treatment? The label indicates it for the topical treatment of acne vulgaris in patients 12 years of age and older. It says it isn’t known whether the cream is safe and effective in children under 12. Whether it suits you depends on a clinician’s review.

How often do you apply Winlevi? The label says to apply a thin uniform layer to the affected area twice per day, in the morning and the evening, after gently cleansing and drying the skin. Your dermatologist’s directions always come first.

What are the most common Winlevi side effects? The label lists redness, itching and scaling or dryness as the most common adverse reactions, at 7 to 12% of patients. It also describes adrenal axis suppression and elevated potassium as safety points to raise with your dermatologist.

Can you get Winlevi online through a dermatologist? TGIC doesn’t list Winlevi and can’t promise any specific medication. A board-certified dermatologist licensed in your state reviews your case, and the dermatologist decides whether any prescription is appropriate. You can start with the quiz, which takes about two minutes.

Is Winlevi the right next step for your acne?

Winlevi is one prescription topical option, and it isn’t a shortcut. The trials show a real but modest advantage over vehicle, and the safety section covers surface area, adrenal symptoms and potassium. If topicals haven’t been enough, our acne treatment comparison lays out the wider options.

TGIC’s men’s FAQ says that if topicals aren’t enough, a board-certified dermatologist may consider oral antibiotics (usually time-limited) or Accutane®. The same applies when acne is moderate to severe, scarring or repeatedly failing appropriate care. See the page on acne treatment for men or getting Accutane® online to learn more.

This article is general information, not medical advice. A prescription is never guaranteed, and treatment decisions stay with the board-certified dermatologist who reviews your case. Winlevi is a trademark of its respective owner, and clascoterone is the generic name. Accutane® is a registered trademark of its respective owner, and isotretinoin is the generic name. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician; independent board-certified dermatologists prescribe.

Sources

General information from published sources, not medical advice. Your dermatologist makes every treatment decision after reviewing your case. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician.

← Blog Home